Supplementary Figure S3 from Negative Hyperselection of Patients with HER2<sup>+</sup> and <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study
Randon G., Nakamura Y., Yaeger R., Lonardi S., Cremolini C., Elez E., Nichetti F., Ghelardi F., Nasca V., Bergamo F., Conca V., Ros J., Bando H., Maddalena G., Oldani S., Prisciandaro M., Raimondi A., Schrock AB., Agnelli L., Walch H., Yoshino T., Pietrantonio F.
<p>Boxplot for HER2 CNV in resistant vs sensitive patients.</p>